| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NAV1 mRNA | 19933214 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of NAV1 mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NAV1 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NAV1 mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of NAV1 mRNA | 28458013 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of NAV1 gene | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of NAV1 gene | 28458013 |
| D016604 | Aflatoxin B1 | decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of NAV1 mRNA] | 28458013 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of NAV1 mRNA | 24449571 |
| D001151 | Arsenic | Arsenic results in decreased expression of NAV1 mRNA | 19654921 |
| C015001 | arsenite | arsenite results in decreased expression of NAV1 mRNA | 23974009 |
| C547126 | AZM551248 | AZM551248 results in increased expression of NAV1 mRNA | 22323515 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of NAV1 mRNA | 20064835 |
| D001564 | Benzo(a)pyrene | [Soot co-treated with Benzo(a)pyrene] results in decreased expression of NAV1 protein modified form | 24464499 |
| D001564 | Benzo(a)pyrene | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of NAV1 mRNA] | 22228805 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NAV1 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased methylation of NAV1 promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A results in increased expression of NAV1 mRNA | 29097150 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA | 28628672 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of NAV1 mRNA | 26079696 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of NAV1 mRNA | 19320972 |
| D005576 | Colforsin | Colforsin results in decreased expression of NAV1 mRNA | 16751804 |
| C014347 | decitabine | decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of NAV1 mRNA] | 28458013 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NAV1 mRNA | 25047013 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NAV1 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA | 28628672 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of NAV1 mRNA | 22733784 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of NAV1 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of NAV1 mRNA | 19561079|2739243 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of NAV1 mRNA | 18042831 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of NAV1 mRNA | 16002434 |
| C118739 | entinostat | entinostat results in decreased expression of NAV1 mRNA | 26272509 |
| C118739 | entinostat | entinostat results in increased expression of NAV1 mRNA | 27188386 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of NAV1 mRNA | 29097150 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of NAV1 mRNA | 28973697 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NAV1 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA | 28628672 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NAV1 mRNA | 25613284 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NAV1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NAV1 mRNA | 28628672 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of NAV1 mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of NAV1 mRNA | 21889194 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA | 21641980 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of NAV1 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of NAV1 mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NAV1 mRNA | 23179753|2627250 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV1 mRNA" | 27188386 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NAV1 mRNA" | 26251327 |
| D015741 | Metribolone | Metribolone results in decreased expression of NAV1 mRNA | 16751804 |
| D009020 | Morphine | Morphine results in decreased expression of NAV1 mRNA | 21178816 |
| C523799 | MRK 003 | NAV1 results in increased susceptibility to MRK 003 | 19903844 |
| D009532 | Nickel | Nickel results in increased expression of NAV1 mRNA | 25583101 |
| C009618 | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | "O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of NAV1 mRNA" | 21673326 |
| C009618 | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | "PON1 protein affects the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of NAV1 mRNA]" | 21673326 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of NAV1 mRNA | 18042831 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of NAV1 mRNA | 26272509 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of NAV1 mRNA | 26272509 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of NAV1 mRNA | 25895662 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of NAV1 mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite results in increased stability of NAV1 mRNA | 25493608 |
| D053260 | Soot | [Soot co-treated with Benzo(a)pyrene] results in decreased expression of NAV1 protein modified form | 24464499 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA | 21641980 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NAV1 mRNA | 17555868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NAV1 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NAV1 mRNA | 19933214 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NAV1 mRNA | 25613284 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of NAV1 mRNA | 28111298 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of NAV1 mRNA | 21934132 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of NAV1 mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in increased expression of NAV1 mRNA | 24935251 |
| C057693 | troglitazone | troglitazone results in increased expression of NAV1 mRNA | 19140230 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of NAV1 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of NAV1 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of NAV1 mRNA | 24935251 |
| D014638 | Vanadates | Vanadates results in increased expression of NAV1 mRNA | 22714537 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of NAV1 gene | 25560391 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in decreased expression of NAV1 mRNA | 26272509 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of NAV1 mRNA | 24714768 |